TrialClinical and vaccine immunology : CVI2009

Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Andrew R Gorringe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.